Clinical Trial

Prognosis of Early-onset Anorexia Nervosa

Study acronym: AM2P
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 3, 2026 (before its estimated March 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The AM2P study aims to evaluate the long-term prognosis and quality of life of patients with early-onset anorexia nervosa, assessed 4 to 9 years after hospitalization. Prognosis will be determined using a composite outcome measure based on questionnaire responses and health indicators, including body mass index (BMI). In addition, the study will examine the patients' overall physical condition both at the time of assessment and during the interval between their last hospitalization and the present evaluation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-16.
Status change: Not Yet Recruiting → Recruiting 2026-02-02
Trial Details
NCT Number NCT07311356
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Conditions Anorexia Nervosa
Enrollment 140 participants
Start Date 2025-12-05
Primary Completion 2026-03-31 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-03